Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124235514> ?p ?o ?g. }
- W2124235514 endingPage "2693" @default.
- W2124235514 startingPage "2687" @default.
- W2124235514 abstract "Mantle cell lymphoma (MCL) is considered incurable. Intensive immunochemotherapy with stem cell support has not been tested in large, prospective series. In the 2nd Nordic MCL trial, we treated 160 consecutive, untreated patients younger than 66 years in a phase 2 protocol with dose-intensified induction immunochemotherapy with rituximab (R) + cyclophosphamide, vincristine, doxorubicin, prednisone (maxi-CHOP), alternating with R + high-dose cytarabine. Responders received high-dose chemotherapy with BEAM or BEAC (carmustine, etoposide, cytarabine, and melphalan/cyclophosphamide) with R-in vivo purged autologous stem cell support. Overall and complete response was achieved in 96% and 54%, respectively. The 6-year overall, event-free, and progression-free survival were 70%, 56%, and 66%, respectively, with no relapses occurring after 5 years. Multivariate analysis showed Ki-67 to be the sole independent predictor of event-free survival. The nonrelapse mortality was 5%. The majority of stem cell products and patients assessed with polymerase chain reaction (PCR) after transplantation were negative. Compared with our historical control, the Nordic MCL-1 trial, the event-free, overall, and progression-free survival, the duration of molecular remission, and the proportion of PCR-negative stem cell products were significantly increased (P < .001). Intensive immunochemotherapy with in vivo purged stem cell support can lead to long-term progression-free survival of MCL and perhaps cure. Registered at www.isrctn.org as #ISRCTN 87866680." @default.
- W2124235514 created "2016-06-24" @default.
- W2124235514 creator A5003376599 @default.
- W2124235514 creator A5011273153 @default.
- W2124235514 creator A5019774051 @default.
- W2124235514 creator A5023859348 @default.
- W2124235514 creator A5028743667 @default.
- W2124235514 creator A5033781914 @default.
- W2124235514 creator A5034388492 @default.
- W2124235514 creator A5037713780 @default.
- W2124235514 creator A5037999437 @default.
- W2124235514 creator A5039524864 @default.
- W2124235514 creator A5040642952 @default.
- W2124235514 creator A5048625888 @default.
- W2124235514 creator A5051340130 @default.
- W2124235514 creator A5054258973 @default.
- W2124235514 creator A5055183115 @default.
- W2124235514 creator A5058855375 @default.
- W2124235514 creator A5062896602 @default.
- W2124235514 creator A5065902991 @default.
- W2124235514 creator A5081888684 @default.
- W2124235514 creator A5085342849 @default.
- W2124235514 creator A5090605318 @default.
- W2124235514 creator A5091072273 @default.
- W2124235514 date "2008-10-01" @default.
- W2124235514 modified "2023-10-17" @default.
- W2124235514 title "Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group" @default.
- W2124235514 cites W1009164044 @default.
- W2124235514 cites W1492275783 @default.
- W2124235514 cites W1912693401 @default.
- W2124235514 cites W192358873 @default.
- W2124235514 cites W1991757117 @default.
- W2124235514 cites W1994161738 @default.
- W2124235514 cites W1996537666 @default.
- W2124235514 cites W2000404575 @default.
- W2124235514 cites W2002456769 @default.
- W2124235514 cites W2036087838 @default.
- W2124235514 cites W2036242721 @default.
- W2124235514 cites W2043275534 @default.
- W2124235514 cites W2044818526 @default.
- W2124235514 cites W2046206081 @default.
- W2124235514 cites W2060908198 @default.
- W2124235514 cites W2087170752 @default.
- W2124235514 cites W2112509952 @default.
- W2124235514 cites W2123236288 @default.
- W2124235514 cites W2125684345 @default.
- W2124235514 cites W2151092645 @default.
- W2124235514 cites W2153569820 @default.
- W2124235514 cites W2155724413 @default.
- W2124235514 cites W2158466638 @default.
- W2124235514 cites W2162109567 @default.
- W2124235514 cites W2236439975 @default.
- W2124235514 cites W2241314352 @default.
- W2124235514 cites W2327039910 @default.
- W2124235514 cites W2562559362 @default.
- W2124235514 cites W2584181040 @default.
- W2124235514 cites W2592106861 @default.
- W2124235514 cites W2980989463 @default.
- W2124235514 cites W2992564836 @default.
- W2124235514 cites W329934425 @default.
- W2124235514 cites W41845000 @default.
- W2124235514 cites W4205736005 @default.
- W2124235514 cites W4293241248 @default.
- W2124235514 doi "https://doi.org/10.1182/blood-2008-03-147025" @default.
- W2124235514 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2556606" @default.
- W2124235514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18625886" @default.
- W2124235514 hasPublicationYear "2008" @default.
- W2124235514 type Work @default.
- W2124235514 sameAs 2124235514 @default.
- W2124235514 citedByCount "561" @default.
- W2124235514 countsByYear W21242355142012 @default.
- W2124235514 countsByYear W21242355142013 @default.
- W2124235514 countsByYear W21242355142014 @default.
- W2124235514 countsByYear W21242355142015 @default.
- W2124235514 countsByYear W21242355142016 @default.
- W2124235514 countsByYear W21242355142017 @default.
- W2124235514 countsByYear W21242355142018 @default.
- W2124235514 countsByYear W21242355142019 @default.
- W2124235514 countsByYear W21242355142020 @default.
- W2124235514 countsByYear W21242355142021 @default.
- W2124235514 countsByYear W21242355142022 @default.
- W2124235514 countsByYear W21242355142023 @default.
- W2124235514 crossrefType "journal-article" @default.
- W2124235514 hasAuthorship W2124235514A5003376599 @default.
- W2124235514 hasAuthorship W2124235514A5011273153 @default.
- W2124235514 hasAuthorship W2124235514A5019774051 @default.
- W2124235514 hasAuthorship W2124235514A5023859348 @default.
- W2124235514 hasAuthorship W2124235514A5028743667 @default.
- W2124235514 hasAuthorship W2124235514A5033781914 @default.
- W2124235514 hasAuthorship W2124235514A5034388492 @default.
- W2124235514 hasAuthorship W2124235514A5037713780 @default.
- W2124235514 hasAuthorship W2124235514A5037999437 @default.
- W2124235514 hasAuthorship W2124235514A5039524864 @default.
- W2124235514 hasAuthorship W2124235514A5040642952 @default.
- W2124235514 hasAuthorship W2124235514A5048625888 @default.
- W2124235514 hasAuthorship W2124235514A5051340130 @default.
- W2124235514 hasAuthorship W2124235514A5054258973 @default.
- W2124235514 hasAuthorship W2124235514A5055183115 @default.